Physician profile
George B Sutherland
NPI 1518177559
$12,593.48
in general payments reported to CMS, 2019-2025
17 companies · $3,404 in 2025
The $3,404 reported for 2025 was more than what 78% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,226 · 2021: $4,716 · 2022: $1,602 · 2023: $246 · 2024: $1,399 · 2025: $3,404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,892 · Food and Beverage: $1,137 · Consulting Fee: $20.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,891.89 |
| Food and Beverage | $1,137.22 |
| Consulting Fee | $20.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Team 1, LLC | $4,328.80 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $2,520.78 | 2019-2025 | Oxford, Oxford Partial Knee, Tapestry |
| Arthrex, INC. | $2,075.45 | 2019-2025 | |
| Catalyst Orthoscience | $1,493.99 | 2022 | |
| Peerless Surgical INC. | $1,024.98 | 2025 | |
| Stryker Corporation | $521.99 | 2021-2024 | Aequalis Perform, Blueprint Patient Specific Instrumentation |
| Acelrx Pharmaceuticals, INC. | $120.58 | 2021 | |
| Smith+Nephew, INC. | $108.45 | 2022 | |
| Integra Lifesciences Corporation | $97.69 | 2019 | |
| Shoulder Innovations, INC. | $88.28 | 2021 | |
| Pacira Therapeutics, INC. | $84.41 | 2019-2021 | |
| Abbvie INC. | $28.69 | 2024 | |
| Medtronic, INC. | $22.20 | 2025 | Plasmablade(Tm) |
| Amag Pharmaceuticals, INC. | $20.67 | 2019 | |
| Next Science LLC | $20.51 | 2024 | Xperience, Surgx, Blastx |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $20.50 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.51 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Sutherland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.